Market Overview

Catalent To Purchase Bristol-Myers Squibb Manufacturing Facility In Italy


Catalent Inc (NYSE: CTLT) will purchase a Bristol-Myers Squibb (NYSE: BMY) manufacturing facility in Anagni, Italy.

No terms have been disclosed yet.

On Wednesday, Catalent shares traded down 0.4% to $50.40. Bristol-Myers Squibb shares traded up 0.59% at $48.05.

Related links:

Nikkei: Apple Could Shift Some Production Capacity Out Of China

My Size Rallies On Integration With 'Global' Apparel Company's E-Commerce Platform

Posted-In: News Asset Sales


Related Articles (BMY + CTLT)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial

UPS Warns Training Regulations Will Hurt Its Long-Haul Driver Hiring

Newmark Group Reports Purchase Of ACRES